Showing results (611-620 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|April 9, 1999
Impressive remission in a patient with locally advanced malignant pleural mesothelioma treated with gemcitabineM Weinmann, A Brandes, J Classen, et al.Anti-Cancer Drugs|April 9, 1999
Pharmacokinetics and central nervous system toxicity of declopramide (3-chloroprocainamide) in rats and miceJ Hua, R W Pero, R KaneAnti-Cancer Drugs|April 9, 1999
Reduction of lung metastasis by ImH[trans-RuCl4(DMSO)Im]: mechanism of the selective action investigated on mouse tumorsG Sava, K Clerici, I Capozzi, et al.Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.Anti-Cancer Drugs|April 11, 2000
Phase II study of docetaxel alternating with cisplatin in chemotherapy-naïve patients with advanced non-small cell lung cancerK Mattson, J Vansteenkiste, R Stupp, et al.Anti-Cancer Drugs|April 11, 2000
Time- and dose-limiting erysipeloid rash confined to areas of lymphedema following treatment with gemcitabine--a report of three casesA Brandes, U Reichmann, L Plasswilm, et al.Anti-Cancer Drugs|April 11, 2000
Expression of inducible nitric oxide synthase (iNOS/NOS II) in the vestibule of guinea pigs after the application of cisplatinK Watanabe, A Hess, W Bloch, et al.Anti-Cancer Drugs|April 11, 2000
Effects of KR-30035, a novel multidrug-resistance modulator, on the cardiovascular system of rats in vivo and on the cell cycle of human cancer cells in vitroB H Lee, H S Shin, C O Lee, et al.Anti-Cancer Drugs|July 8, 2000
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancerF Ravandi, M E Rytting, C Osmon, et al.Pageof 464